Centre exempts import duty on drugs, food for special medical purposes for personal use to treat rare diseases

The move would facilitate the smooth availability of drugs for the treatment of critical and rare diseases, official sources said

PGurus Newsdesk

March 30, 2023

The move would facilitate the smooth availability of drugs for the treatment of critical and rare diseases, official sources said

Major step by the Central government

The Central government has taken a major step to give full exemption from basic customs duty on all medication and food for medical purposes imported for handling rare diseases and personal use under the National Policy for Rare Diseases 2021 through a general exemption notification. This would facilitate the smooth availability of drugs for treating critical and rare diseases, official sources said.

The government has also fully exempted Pembrolizumab (Keytruda), used in the treatment of various forms of cancers, from basic customs duty.

Drugs or medicines generally attract basic customs duty of 10 percent, while some categories of life-saving drugs and vaccines attract a concessional rate of 5 percent or nil charges.

To avail of this exemption, the individual importer has to produce a certificate from the central or state director of health services or from the district medical officer or civil surgeon of the district.

While exemptions have already been provided to specified drugs for the treatment of spinal muscular atrophy or Duchenne muscular dystrophy, the government has been receiving many representations seeking customs duty relief for drugs and medicines used in the treatment of other rare diseases.

Drugs or special foods required for the treatment of these diseases are expensive and need to be imported. It is estimated that for a child weighing 10 kg, the annual cost of treatment for some rare diseases may vary from Rs.10 lakh to more than Rs.1 crore per year with treatment being lifelong and drug dose and cost, increasing with age and weight. This exemption will result in substantial cost savings and provide patients with much-needed relief.

[With Inputs from IANS]

PGurus is now on Telegram. Click here to join our channel and stay updated with all the latest news and views

For all the latest updates, download PGurus App.